一个多中心随机对照的临床试验,用于治疗食道状细胞癌的辅助剂sintilimab
Hai-Bo Sun1, Wen-Qun Xing1, Xian-Ben Liu1
1Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Future oncology (London, England)
|September 22, 2023
概括
辅助剂辛提利马布在高风险食道状细胞癌 (ESCC) 患者的手术后显示出前景. 这项试验调查了sintilimab.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 胃肠道癌症研究研究
背景情况:
- 对于高复发风险或淋巴结转移的食道状细胞癌 (ESCC) 患者,缺乏辅助治疗选择.
- 术后的新辅助化疗是标准的治疗方法,但残留疾病需要进一步的管理策略.
研究的目的:
- 评估助剂辛蒂利马布在切除局部发达ESCC的患者中的疗效和生存益处.
- 为解决临床争议围绕辅助免疫疗法高风险ESCC患者.
主要方法:
- 进行了一项开放的,多中心的,III期随机对照试验 (NCT05495152).
- 患者包括那些在新辅助化疗和手术后没有达到病理完整反应的患者,以及临床T1-2 N0患者,有偶发的淋巴结转移.
- 参与者被随机分为2:1接受sintilimab或观察管理.
主要成果:
- 主要终点是所有随机选择的患者的无病生存期.
- 结果提供了关于助剂辛提利马布治疗对生存益处的数据.
- 这项研究解决了关于辅助剂sintilimab在切除局部先进ESCC中的疗效的争议.
结论:
- 这项研究提供了关键的见解助剂sintilimab对于切除局部晚期食道状细胞癌的作用.
- 这些发现有助于为高风险ESCC患者建立潜在的新护理标准.
- 预计试验结果将指导未来的治疗决策和临床实践.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Esophageal Strictures-II: Clinical Features and Management
96
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
96
Esophageal Varices-II: Clinical Features and Management
86
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
86
